Evaluation of Targeted Prostate Biopsies Under MRI: Tolerance and Contribution in the Therapeutic Decision - Exploratory Study (BIOPROSTATIRM)
Prostate Cancer
About this trial
This is an interventional diagnostic trial for Prostate Cancer
Eligibility Criteria
Inclusion Criteria: Patient, male, aged between ≥ 50 and ≤ 75 years old Patient with no history of prostate biopsy Patient with a PSA greater than 4 and/or a pathological digital rectal examination Patient having an MRI of interpretable quality carried out within the HPA Patient with a single lesion with a PI-RADS score ≥ 3 Affiliated patient or beneficiary of a social security scheme French-speaking patient who signed an informed consent Exclusion Criteria: Patient with a contraindication to MRI Patient with multiple targets Patient with lesions with PI-RADS score 1 and 2 Patient on long-term anticoagulants and unable to stop it Patient already included in another study Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision Patient hospitalized without consent
Sites / Locations
- HPARecruiting
Arms of the Study
Arm 1
Experimental
Biopsy under MRI